Bingcang Huang

Dr. Bingcang Huang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
HHHui Huang
Hui Huang
CDCaihong Dong
Caihong Dong
WFWei Feng
Wei Feng
YWYing Wang
Ying Wang
BHBingcang Huang
Bingcang Huang
Yu ChenYu Chen
Yu Chen

21 April 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
JJJiehui Jiang
Jiehui Jiang
JZJieming Zhang
Jieming Zhang
ZLZhuoyuan Li
Zhuoyuan Li
LLLanlan Li
Lanlan Li
BHBingcang Huang
Bingcang Huang
AIAlzheimer’s Disease Neuroimaging Initiative
Alzheimer’s Disease Neuroimaging Initiative
Objectives: We proposed a novel deep learning radiomics (DLR) method to distinguish cognitively normal adults at risk of Alzheimer’s disease (AD) from normal control based on T1-weighted structural MRI images.Methods: In this study, we selected MRI data from the Alzheimer’s Disease Neuroimaging Initiative Database (ADNI), which included 417 cognitively normal adults. These subjects were divided into 181 individuals at risk of Alzheimer’s disease (preAD group) and 236 normal control individuals (NC group) according to standard uptake ratio >1.18 calculated by amyloid Positron Emission Tomography (PET). We further divided the preaAD group into APOE+ and APOE− subgroups according to whether APOE ε4 was positive or not. All data sets were divided into one training/validation group and one independent test group. The proposed DLR method included three steps: (1) the pre-training of basic deep learning (DL) models, (2) the extraction, selection and fusion of DLR features, and (3) classification. The support vector machine (SVM) was used as the classifier. In the comparative experiments, we compared our proposed DLR method with three existing models: hippocampal model, clinical model, and traditional radiomics model. Ten-fold cross-validation was performed with 100 time repetitions.Results: The DLR method achieved the best classification performance between preAD and NC than other models with an accuracy of 89.85% ± 1.12%. In comparison, the accuracies of the other three models were 72.44% ± 1.37%, 82.00% ± 4.09% and 79.65% ± 2.21%. In addition, the DLR model also showed the best classification performance (85.45% ± 9.04% and 92.80% ± 2.61%) in the subgroup experiment.Conclusion: The results showed that the DLR method provided a potentially clinical value to distinguish preAD from NC.

19 August 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
WLWeiping Lu
Weiping Lu
JWJianguo Wei
Jianguo Wei
TXTingting Xu
Tingting Xu
MDMiao Ding
Miao Ding
XLXiaoyan Li
Xiaoyan Li
BHBingcang Huang
Bingcang Huang
Background: Corona Virus Disease 2019 (COVID-19) is currently a worldwide pandemic and has a huge impact on public health and socio-economic development. The purpose of this study is to explore the diagnostic value of the quantitative computed tomography (CT) method by using different threshold segmentation techniques to distinguish between patients with or without COVID-19 pneumonia.Methods: A total of 47 patients with suspected COVID-19 were retrospectively analyzed, including nine patients with positive real-time fluorescence reverse transcription polymerase chain reaction (RT-PCR) test (confirmed case group) and 38 patients with negative RT-PCR test (excluded case group). An improved 3D convolutional neural network (VB-Net) was used to automatically extract lung lesions. Eight different threshold segmentation methods were used to define the ground glass opacity (GGO) and consolidation. The receiver operating characteristic (ROC) curves were used to compare the performance of various parameters with different thresholds for diagnosing COVID-19 pneumonia.Results: The volume of GGO (VOGGO) and GGO percentage in the whole lung (GGOPITWL) were the most effective values for diagnosing COVID-19 at a threshold of − 300 HU, with areas under the curve (AUCs) of 0.769 and 0.769, sensitivity of 66.67 and 66.67%, specificity of 94.74 and 86.84%. Compared with VOGGO or GGOPITWL at a threshold of − 300 Hounsfield units (HU), the consolidation percentage in the whole lung (CPITWL) with thresholds at − 400 HU, − 350 HU, and − 250 HU were statistically different. There were statistical differences in the infection volume and percentage of the whole lung, right lung, and lobes between the two groups. VOGGO, GGOPITWL, and volume of consolidation (VOC) were also statistically different at the threshold of − 300 HU.Conclusions: Quantitative CT provides an image quantification method for the auxiliary diagnosis of COVID-19 and is expected to assist in confirming patients with COVID-19 pneumonia in suspected cases.

1 March 2022 in Microvascular Research
Verified
Journal Article
Closed access
GPGang Peng
Gang Peng
WLWeiping Lu
Weiping Lu
KCKai Chen
Kai Chen
XYXiaodan Yang
Xiaodan Yang
JWJianguo Wei
Jianguo Wei
BHBingcang Huang
Bingcang Huang

19 December 2025 in Biomaterials
Verified
Journal Article
Closed access
LLLan Luo
Lan Luo
MCMeiqi Chang
Meiqi Chang
YWYing Wang
Ying Wang
Yu ChenYu Chen
Yu Chen
BHBingcang Huang
Bingcang Huang

22 July 2025 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
JJJuanjuan Jiang
Juanjuan Jiang
TKTao Kang
Tao Kang
RLRonghua Ling
Ronghua Ling
YLYingqian Liu
Yingqian Liu
JSJiuai Sun
Jiuai Sun
BHBingcang Huang
Bingcang Huang
Background: Alzheimer’s disease (AD) requires early intervention at preclinical stages like subjective memory complaints (SMC). Traditional static brain network analyses lack sensitivity to detect early functional disruptions in SMC. This study aimed to improve preclinical AD stratification by integrating dynamic gray-white matter functional connectivity (DFC) and machine learning.Methods: Using multi-cohort ADNI data [N = 1,415 participants across cognitive normal[CN], SMC, and cognitive impairment [CI]groups],dynamic functional networks were constructed via sliding-window analysis (20–50 TR windows, 98% overlap) of 200 gray matter (Schaefer atlas) and 128 data-driven white matter nodes. DFC metrics (standard deviation of Fisher z-transformed correlations) were used to identify group differences and classify AD spectrum stages. Support vector machine (SVM) models were trained to differentiate CN/SMC/CI, with subgroup analyses in Aβ + and APOE E4 + populations.Results: DFC with short sliding windows (20–50 TRs, 98% overlap) demonstrated greater sensitivity than SFC in detecting early functional disruptions in gray-white matter networks, identifying 34 CN-SMC [p < 0.05, e.g., ventral attention network (VAN)-white matter 2 (WM2) via Gau20-DFC], 44 CN-CI (p < 0.001), and 49 SMC-CI (p < 0.01) differential connections. Key early abnormalities were identified in the anterior cingulate network (WM4) and sensorimotor network (WM5), with WM4-WM5 disconnections in Aβ + subgroups strongly correlated with Aβ deposition and APOE ε4 genotype. Dynamic graph theory models using SVM achieved superior AD spectrum classification (ADNI2/3 AUCs: 0.85–0.92 vs. static 0.77–0.87), particularly in Aβ + subgroups (ΔAUC = 0.15 for SMC+/CI + discrimination, p < 0.001), with the VAN-WM2 feature in short-window DFC strongly correlating with cognitive scales (MMSE: r = 0.40, p < 10−11; CDR-SB: r = −0.41, p < 10−12). Window function type (e.g., Gau20 for early changes, Ham50 for late stability) and data sampling points influenced sensitivity, with short windows optimizing early detection and long windows capturing late-stage network degeneration. These findings establish dynamic gray-white matter connectivity, particularly WM4-WM5 disruptions and VAN-WM2/DMN-WM8 features, as sensitive preclinical AD biomarkers enabled by machine learning for early SMC stratification.Conclusion: This study confirms that dynamic gray-white matter connectivity serves as a sensitive biomarker for preclinical Alzheimer’s disease. The WM4-WM5 disruption hub and machine learning framework provide effective tools for early stratification of SMC, facilitating timely intervention within the disease’s therapeutic window.